About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Dasiglucagon
- Company
- Novo Nordisk A/S
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- None currently listed
Efficacy results: Not yet reported
No recruiting studies currently listed
See all studies for this drugData source: ClinicalTrials.gov · trial data as of Sep 11, 2026
Trial details
-
Completed NCT NCT02916251
ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon
Not yet reported Zealand Pharma 38 participants Est. completion 2017-04-05 1 site Stand-aloneOther conditions: Diabetes Mellitus Type 1View official trial listing → -
Completed NCT NCT02971228
Feasibility Trial Testing the Bionic Pancreas With ZP4207
Not yet reported Zealand Pharma 13 participants Est. completion 2017-06-07 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03216226
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
Not yet reported Zealand Pharma 112 participants Est. completion 2018-02-13 7 sites Stand-aloneOther conditions: Hypoglycemia, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03378635
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
Not yet reported Zealand Pharma 170 participants Est. completion 2018-05-25 5 sites Stand-aloneOther conditions: Hypoglycemia, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03667053
Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children
Not yet reported Zealand Pharma 42 participants Est. completion 2019-06-28 5 sites Stand-aloneOther conditions: HypoglycemiaView official trial listing → -
Completed NCT NCT03688711
Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM
Not yet reported Zealand Pharma 45 participants Est. completion 2019-03-11 3 sites Stand-aloneOther conditions: Hypoglycemia, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03735225
Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration
Not yet reported Zealand Pharma 60 participants Est. completion 2019-06-24 1 site Stand-aloneOther conditions: HypoglycemiaView official trial listing → -
Completed NCT NCT03777176
A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
Not yet reported Zealand Pharma 32 participants Est. completion 2020-10-05 10 sites Stand-aloneOther conditions: Congenital HyperinsulinismView official trial listing → -
Completed NCT NCT03840278
The Bihormonal iLet Bionic Pancreas Feasibility Study
Not yet reported, Not yet reported Massachusetts General Hospital 12 participants Est. completion 2019-07-03 1 site Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03895697
A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM
Not yet reported Zealand Pharma 92 participants Est. completion 2019-07-30 1 site Stand-aloneOther conditions: Hypoglycemia, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03941236
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism
Not yet reported Zealand Pharma 42 participants Est. completion 2026-05-26 10 sites Stand-aloneOther conditions: Congenital HyperinsulinismView official trial listing → -
Completed NCT NCT03984370
Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass
Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2020-02-26 1 site Stand-aloneOther conditions: Hyperinsulinemic Hypoglycemia, Postprandial HypoglycemiaView official trial listing → -
Completed NCT NCT04172441
Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
Not yet reported, Not yet reported Zealand Pharma 12 participants Est. completion 2022-03-07 6 sites Stand-aloneOther conditions: Congenital HyperinsulinismView official trial listing → -
Withdrawn NCT NCT04192019
Micro Glucagon During Exercise in Type 1 Diabetes
Not yet reported Insel Gruppe AG, University Hospital Bern Est. completion 2024-06 Stand-aloneOther conditions: Type 1 Diabetes, HypoglycemiaView official trial listing → -
Completed NCT NCT04449692
Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes
Not yet reported Steno Diabetes Center Copenhagen 20 participants Est. completion 2021-01-04 1 site Stand-aloneOther conditions: Type 1 Diabetes, HypoglycemiaView official trial listing → -
Completed NCT NCT04764968
Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes
Not yet reported Steno Diabetes Center Copenhagen 24 participants Est. completion 2022-01-28 1 site Stand-aloneOther conditions: Type 1 Diabetes, HypoglycemiaView official trial listing → -
Withdrawn NCT NCT04824872
Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults
Not yet reported Zealand Pharma Est. completion 2023-02 Stand-aloneOther conditions: Hypoglycemia, Glucose Metabolism DisordersView official trial listing → -
Completed NCT NCT04836273
Treatment of Post-bariatric Hypoglycaemia
Not yet reported Filip Krag Knop 24 participants Est. completion 2022-12-15 1 site Stand-aloneOther conditions: Hyperinsulinemic Hypoglycemia, Postprandial HypoglycemiaView official trial listing → -
Completed NCT NCT05378672
A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D
Not yet reported Zealand Pharma 8 participants Est. completion 2024-12-03 2 sites Stand-aloneOther conditions: Hypoglycemia, Type 1 DiabetesView official trial listing → -
Withdrawn NCT NCT05454709
A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System
Not yet reported Inreda Diabetic B.V. Est. completion 2023-12-29 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT06588504
Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents
Not yet reported Novo Nordisk A/S 38 participants Est. completion 2025-07-20 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.